WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES REDHILL BIOPHARMA LTD.RedHill Biopharma Ltd. • May 11th, 2022 • Pharmaceutical preparations
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 11, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 11, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from RedHill Biopharma Ltd., a company organized under the laws of the State of Israel (the “Company”), up to _________ Ordinary Shares, par value NIS 0.01 per share, of the Company (the “Warrant Shares”) represented by _________American Depositary Shares (each, an “ADS” and, collectively, the “ADSs” and the ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exerci
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 11th, 2022 • RedHill Biopharma Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 9, 2022, between RedHill Biopharma Ltd., a company organized under the laws of Israel (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
